via Wistar Institute
Wistar Institute scientists have discovered a new class of compounds that uniquely combine direct antibiotic killing of pan drug-resistant bacterial pathogens with a simultaneous rapid immune response for combatting antimicrobial resistance (AMR).
These finding were published today in Nature.
The World Health Organization (WHO) has declared AMR as one of the top 10 global public health threats against humanity. It is estimated that by 2050, antibiotic-resistant infections could claim 10 million lives each year and impose a cumulative $100 trillion burden on the global economy. The list of bacteria that are becoming resistant to treatment with all available antibiotic options is growing and few new drugs are in the pipeline, creating a pressing need for new classes of antibiotics to prevent public health crises.
“We took a creative, double-pronged strategy to develop new molecules that can kill difficult-to-treat infections while enhancing the natural host immune response,” said Farokh Dotiwala, M.B.B.S., Ph.D., assistant professor in the Vaccine & Immunotherapy Center and lead author of the effort to identify a new generation of antimicrobials named dual-acting immuno-antibiotics (DAIAs).
Existing antibiotics target essential bacterial functions, including nucleic acid and protein synthesis, building of the cell membrane, and metabolic pathways. However, bacteria can acquire drug resistance by mutating the bacterial target the antibiotic is directed against, inactivating the drugs or pumping them out.
“We reasoned that harnessing the immune system to simultaneously attack bacteria on two different fronts makes it hard for them to develop resistance,” said Dotiwala.
He and colleagues focused on a metabolic pathway that is essential for most bacteria but absent in humans, making it an ideal target for antibiotic development. This pathway, called methyl-D-erythritol phosphate (MEP) or non-mevalonate pathway, is responsible for biosynthesis of isoprenoids — molecules required for cell survival in most pathogenic bacteria. The lab targeted the IspH enzyme, an essential enzyme in isoprenoid biosynthesis, as a way to block this pathway and kill the microbes. Given the broad presence of IspH in the bacterial world, this approach may target a wide range of bacteria.
Researchers used computer modeling to screen several million commercially available compounds for their ability to bind with the enzyme, and selected the most potent ones that inhibited IspH function as starting points for drug discovery.
Since previously available IspH inhibitors could not penetrate the bacterial cell wall, Dotiwala collaborated with Wistar’s medicinal chemist Joseph Salvino, Ph.D., professor in The Wistar Institute Cancer Center and a co-senior author on the study, to identify and synthesize novel IspH inhibitor molecules that were able to get inside the bacteria.
The team demonstrated that the IspH inhibitors stimulated the immune system with more potent bacterial killing activity and specificity than current best-in-class antibiotics when tested in vitro on clinical isolates of antibiotic-resistant bacteria, including a wide range of pathogenic gram negative and gram positive bacteria. In preclinical models of gram negative bacterial infection, the bactericidal effects of the IspH inhibitors outperformed traditional pan antibiotics. All compounds tested were shown to be nontoxic to human cells.
“Immune activation represents the second line of attack of the DAIA strategy,” said Kumar Singh, Ph.D., Dotiwala lab postdoctoral fellow and first author of the study.
“We believe this innovative DAIA strategy may represent a potential landmark in the world’s fight against AMR, creating a synergy between the direct killing ability of antibiotics and the natural power of the immune system,” echoed Dotiwala.
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
New class of antibiotics
- Three found guilty of drugs and firearms offences
Three men have been convicted after being found in possession of a sawn off shotgun and a quantity of drugs. On 19 November 2020, officers patrolling Rotherhithe New Road, SE16, noticed the occupants ...
- New computer modelling could boost drug discovery
Scientists from Queen's University Belfast have developed a computer-aided data tool that could improve treatment for a range of illnesses.
- Recce Pharmaceuticals Receives Ethics Approval to Start Phase I Intravenous Clinical Trial of RECCE® 327
Highlights: Phase I clinical trial of RECCE ® 327 approved to start intravenous ascending-dose, randomized, placebo-controlled, parallel, double-blind, single-dose study; Accordi ...
- ContraFect to Present Data on the Potential of DLAs to Treat Pulmonary Infections in Cystic Fibrosis Patients
YONKERS, N.Y., Oct. 26, 2021 (GLOBE NEWSWIRE) -- (Nasdaq: CFRX), a late clinical-stage biotechnology company focused on the discovery and development of direct lytic agents (DLAs), including lysins ...
- Researchers reveal mechanism which allows antibiotics like penicillin to kill MRSA
The mechanism which allows β-lactam antibiotics, including penicillin, to kill MRSA has been revealed for the first time.
Go deeper with Google Headlines on:
New class of antibiotics
Go deeper with Bing News on:
Drug-resistant bacterial pathogens
- New Way to Target and Kill Antibiotic-Resistant Bacteria Found (IMAGE)
Antibiotic resistance propagates in bacteria by moving DNA strands containing the resistance genes to neighboring cells. An enzyme called relaxase is essential for this process. Bisphosphonates, ...
- Sharpest ever images of live bacteria unravel the secrets of superbugs
By using a nanoscale needle tip to probe the intricate exterior structures of Escherichia coli, scientists have produced the sharpest images ever of living bacteria. With this new perspective of its ...
- Sharpest ever images of living bacteria reveal unexpected membrane structure
Using a microscopy technique that pulls back the curtain on the nanoscale world, researchers have generated the sharpest images of live bacteria ever taken. The high-resolution snaps reveal a ...
- Permafrost thaw could release bacteria and viruses
When considering the implications of thawing permafrost, our initial worries are likely to turn to the major issue of methane being released into the atmosphere and exacerbating global warming or ...
- Emerging Antibiotic Resistance Predicted With Machine Learning
Many novel traits are shared through gene transfer, but scientists haven’t been able to determine why some bacteria engage in gene transfer while others do not.